Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)
China
· Delayed Price · Currency is CNY 30.13
-0.51 (-1.66%)
May 22, 2025, 2:45 PM CST
SHA:688180 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,995 | 1,876 | 1,474 | 1,229 | 3,768 | 1,507 | Upgrade
|
| Other Revenue | 72.73 | 72.73 | 28.4 | 224.26 | 257.09 | 87.52 | Upgrade
|
| Revenue | 2,068 | 1,948 | 1,503 | 1,453 | 4,025 | 1,595 | Upgrade
|
| Revenue Growth (YoY) | 27.02% | 29.67% | 3.38% | -63.89% | 152.36% | 105.77% | Upgrade
|
| Cost of Revenue | 509.34 | 523.54 | 634.39 | 526.28 | 1,258 | 376.76 | Upgrade
|
| Gross Profit | 1,559 | 1,425 | 868.16 | 927.21 | 2,767 | 1,218 | Upgrade
|
| Selling, General & Admin | 1,516 | 1,508 | 1,381 | 1,285 | 1,377 | 1,128 | Upgrade
|
| Research & Development | 1,350 | 1,275 | 1,937 | 2,384 | 2,069 | 1,778 | Upgrade
|
| Other Operating Expenses | 16.22 | 10.35 | 7.54 | 6.03 | 7.07 | 7.72 | Upgrade
|
| Operating Expenses | 2,867 | 2,779 | 3,344 | 3,675 | 3,453 | 2,913 | Upgrade
|
| Operating Income | -1,308 | -1,354 | -2,476 | -2,748 | -686.06 | -1,695 | Upgrade
|
| Interest Expense | -56.48 | -51.35 | -29.01 | -29.37 | -21.83 | -29.39 | Upgrade
|
| Interest & Investment Income | 37.08 | 43.63 | 173.42 | 61.02 | 30.98 | 20.28 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.27 | 8.27 | -2.66 | 50.05 | -39.94 | -11.67 | Upgrade
|
| Other Non Operating Income (Expenses) | 33.77 | 29.33 | -38.71 | -0.8 | 0.13 | -0.99 | Upgrade
|
| EBT Excluding Unusual Items | -1,285 | -1,324 | -2,373 | -2,667 | -716.72 | -1,717 | Upgrade
|
| Gain (Loss) on Sale of Investments | -73.34 | -71.23 | -149.18 | -51.21 | 65.75 | 40.42 | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.33 | 11.84 | 28.89 | 22.37 | 0.78 | 1.12 | Upgrade
|
| Asset Writedown | -12.13 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 27.33 | 25.89 | 1.55 | 18.73 | 55.2 | 2.84 | Upgrade
|
| Pretax Income | -1,348 | -1,358 | -2,492 | -2,677 | -595 | -1,672 | Upgrade
|
| Income Tax Expense | -7.8 | 22.55 | 43.99 | -93.11 | 135.53 | -3.82 | Upgrade
|
| Earnings From Continuing Operations | -1,340 | -1,380 | -2,536 | -2,584 | -730.53 | -1,669 | Upgrade
|
| Net Income to Company | -1,340 | -1,380 | -2,536 | -2,584 | -730.53 | -1,669 | Upgrade
|
| Minority Interest in Earnings | 107.27 | 99.18 | 252.26 | 196.03 | 9.62 | 0 | Upgrade
|
| Net Income | -1,233 | -1,281 | -2,283 | -2,388 | -720.91 | -1,669 | Upgrade
|
| Net Income to Common | -1,233 | -1,281 | -2,283 | -2,388 | -720.91 | -1,669 | Upgrade
|
| Shares Outstanding (Basic) | 986 | 985 | 984 | 918 | 890 | 822 | Upgrade
|
| Shares Outstanding (Diluted) | 986 | 985 | 984 | 918 | 890 | 822 | Upgrade
|
| Shares Change (YoY) | 0.49% | 0.11% | 7.16% | 3.20% | 8.28% | 5.58% | Upgrade
|
| EPS (Basic) | -1.25 | -1.30 | -2.32 | -2.60 | -0.81 | -2.03 | Upgrade
|
| EPS (Diluted) | -1.25 | -1.30 | -2.32 | -2.60 | -0.81 | -2.03 | Upgrade
|
| Free Cash Flow | -1,721 | -2,125 | -2,838 | -2,170 | -1,507 | -2,037 | Upgrade
|
| Free Cash Flow Per Share | -1.75 | -2.16 | -2.88 | -2.36 | -1.69 | -2.48 | Upgrade
|
| Gross Margin | 75.37% | 73.13% | 57.78% | 63.79% | 68.74% | 76.38% | Upgrade
|
| Operating Margin | -63.25% | -69.49% | -164.79% | -189.06% | -17.05% | -106.28% | Upgrade
|
| Profit Margin | -59.61% | -65.75% | -151.97% | -164.30% | -17.91% | -104.62% | Upgrade
|
| Free Cash Flow Margin | -83.24% | -109.06% | -188.85% | -149.31% | -37.44% | -127.71% | Upgrade
|
| EBITDA | -1,052 | -1,094 | -2,204 | -2,513 | -476.32 | -1,576 | Upgrade
|
| EBITDA Margin | -50.84% | -56.16% | -146.66% | -172.86% | -11.83% | -98.80% | Upgrade
|
| D&A For EBITDA | 256.48 | 259.65 | 272.32 | 235.47 | 209.74 | 119.31 | Upgrade
|
| EBIT | -1,308 | -1,354 | -2,476 | -2,748 | -686.06 | -1,695 | Upgrade
|
| EBIT Margin | -63.25% | -69.49% | -164.79% | -189.06% | -17.04% | -106.28% | Upgrade
|
| Revenue as Reported | 2,068 | 1,948 | 1,503 | 1,453 | 4,025 | 1,595 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.